nodes	percent_of_prediction	percent_of_DWPC	metapath
Acebutolol—Propranolol—migraine	0.415	1	CrCtD
Acebutolol—Metipranolol—Propranolol—migraine	0.0379	0.136	CrCrCtD
Acebutolol—ADRB2—Timolol—migraine	0.036	0.167	CbGbCtD
Acebutolol—ADRB1—Timolol—migraine	0.0354	0.165	CbGbCtD
Acebutolol—Betaxolol—Propranolol—migraine	0.0323	0.116	CrCrCtD
Acebutolol—ADRB2—Propranolol—migraine	0.0321	0.149	CbGbCtD
Acebutolol—ADRB1—Propranolol—migraine	0.0316	0.147	CbGbCtD
Acebutolol—Bisoprolol—Propranolol—migraine	0.0301	0.108	CrCrCtD
Acebutolol—Alprenolol—Propranolol—migraine	0.0266	0.0955	CrCrCtD
Acebutolol—Metoprolol—Propranolol—migraine	0.0266	0.0955	CrCrCtD
Acebutolol—Oxprenolol—Propranolol—migraine	0.0266	0.0955	CrCrCtD
Acebutolol—Practolol—Propranolol—migraine	0.0266	0.0955	CrCrCtD
Acebutolol—Atenolol—Propranolol—migraine	0.0252	0.0904	CrCrCtD
Acebutolol—Esmolol—Propranolol—migraine	0.0239	0.0858	CrCrCtD
Acebutolol—Pindolol—Propranolol—migraine	0.0228	0.0818	CrCrCtD
Acebutolol—SLC22A1—Verapamil—migraine	0.0191	0.0889	CbGbCtD
Acebutolol—ABCB1—Timolol—migraine	0.00958	0.0445	CbGbCtD
Acebutolol—CYP2D6—Timolol—migraine	0.00902	0.042	CbGbCtD
Acebutolol—ABCB1—Propranolol—migraine	0.00853	0.0397	CbGbCtD
Acebutolol—CYP2D6—Propranolol—migraine	0.00804	0.0374	CbGbCtD
Acebutolol—ABCB1—Amitriptyline—migraine	0.00738	0.0343	CbGbCtD
Acebutolol—CYP2D6—Amitriptyline—migraine	0.00696	0.0323	CbGbCtD
Acebutolol—ABCB1—Verapamil—migraine	0.00586	0.0272	CbGbCtD
Acebutolol—CYP2D6—Verapamil—migraine	0.00552	0.0257	CbGbCtD
Acebutolol—ADRB1—Endothelin Pathways—CALCRL—migraine	0.000667	0.038	CbGpPWpGaD
Acebutolol—ADRB1—Endothelin Pathways—RAMP1—migraine	0.000667	0.038	CbGpPWpGaD
Acebutolol—ADRB1—Monoamine GPCRs—HTR1D—migraine	0.000484	0.0276	CbGpPWpGaD
Acebutolol—ADRB2—Monoamine GPCRs—HTR1D—migraine	0.000474	0.027	CbGpPWpGaD
Acebutolol—ADRB1—Monoamine GPCRs—HTR2B—migraine	0.00045	0.0256	CbGpPWpGaD
Acebutolol—ADRB2—Monoamine GPCRs—HTR2B—migraine	0.00044	0.0251	CbGpPWpGaD
Acebutolol—ADRB1—Amine ligand-binding receptors—HTR1D—migraine	0.000407	0.0232	CbGpPWpGaD
Acebutolol—ADRB2—Amine ligand-binding receptors—HTR1D—migraine	0.000398	0.0227	CbGpPWpGaD
Acebutolol—ADRB1—Amine ligand-binding receptors—HTR2B—migraine	0.000379	0.0216	CbGpPWpGaD
Acebutolol—ADRB2—Amine ligand-binding receptors—HTR2B—migraine	0.00037	0.0211	CbGpPWpGaD
Acebutolol—Pindolol—HTR1B—migraine	0.000329	0.271	CrCbGaD
Acebutolol—Alprenolol—HTR1A—migraine	0.000302	0.249	CrCbGaD
Acebutolol—ADRB1—Monoamine GPCRs—HTR1B—migraine	0.000293	0.0167	CbGpPWpGaD
Acebutolol—ADRB2—Monoamine GPCRs—HTR1B—migraine	0.000287	0.0164	CbGpPWpGaD
Acebutolol—ADRB1—Monoamine GPCRs—HTR1A—migraine	0.000282	0.0161	CbGpPWpGaD
Acebutolol—ADRB2—Monoamine GPCRs—HTR1A—migraine	0.000276	0.0157	CbGpPWpGaD
Acebutolol—ADRB1—Monoamine GPCRs—HTR2C—migraine	0.000273	0.0155	CbGpPWpGaD
Acebutolol—ADRB2—Monoamine GPCRs—HTR2C—migraine	0.000267	0.0152	CbGpPWpGaD
Acebutolol—ADRB1—Endothelin Pathways—EDNRA—migraine	0.000265	0.0151	CbGpPWpGaD
Acebutolol—Pindolol—HTR1A—migraine	0.00026	0.215	CrCbGaD
Acebutolol—ADRB1—Endothelin Pathways—CALCA—migraine	0.000255	0.0146	CbGpPWpGaD
Acebutolol—ADRB1—Amine ligand-binding receptors—HTR1B—migraine	0.000247	0.0141	CbGpPWpGaD
Acebutolol—ADRB2—Amine ligand-binding receptors—HTR1B—migraine	0.000241	0.0137	CbGpPWpGaD
Acebutolol—ADRB1—Monoamine GPCRs—HTR7—migraine	0.000239	0.0136	CbGpPWpGaD
Acebutolol—ADRB1—Amine ligand-binding receptors—HTR1A—migraine	0.000237	0.0135	CbGpPWpGaD
Acebutolol—ADRB2—Monoamine GPCRs—HTR7—migraine	0.000234	0.0133	CbGpPWpGaD
Acebutolol—ADRB2—Amine ligand-binding receptors—HTR1A—migraine	0.000232	0.0132	CbGpPWpGaD
Acebutolol—ADRB1—G alpha (s) signalling events—RAMP1—migraine	0.000231	0.0132	CbGpPWpGaD
Acebutolol—ADRB1—G alpha (s) signalling events—CALCRL—migraine	0.000231	0.0132	CbGpPWpGaD
Acebutolol—ADRB1—Amine ligand-binding receptors—HTR2C—migraine	0.000229	0.0131	CbGpPWpGaD
Acebutolol—ADRB2—G alpha (s) signalling events—RAMP1—migraine	0.000226	0.0129	CbGpPWpGaD
Acebutolol—ADRB2—G alpha (s) signalling events—CALCRL—migraine	0.000226	0.0129	CbGpPWpGaD
Acebutolol—ADRB2—Amine ligand-binding receptors—HTR2C—migraine	0.000224	0.0128	CbGpPWpGaD
Acebutolol—ADRB1—Amine ligand-binding receptors—HTR7—migraine	0.000201	0.0114	CbGpPWpGaD
Acebutolol—ADRB2—Amine ligand-binding receptors—HTR7—migraine	0.000196	0.0112	CbGpPWpGaD
Acebutolol—Propranolol—HTR1B—migraine	0.000179	0.148	CrCbGaD
Acebutolol—ADRB1—Monoamine GPCRs—HTR2A—migraine	0.000167	0.00953	CbGpPWpGaD
Acebutolol—SLC22A1—Neuronal System—KCNK18—migraine	0.000166	0.00947	CbGpPWpGaD
Acebutolol—ADRB2—Monoamine GPCRs—HTR2A—migraine	0.000164	0.00933	CbGpPWpGaD
Acebutolol—ADRB1—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.000151	0.00862	CbGpPWpGaD
Acebutolol—ADRB2—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.000148	0.00843	CbGpPWpGaD
Acebutolol—Propranolol—HTR1A—migraine	0.000142	0.117	CrCbGaD
Acebutolol—ADRB1—Amine ligand-binding receptors—HTR2A—migraine	0.000141	0.00801	CbGpPWpGaD
Acebutolol—ADRB2—Amine ligand-binding receptors—HTR2A—migraine	0.000138	0.00784	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Other—EDNRA—migraine	0.000115	0.00657	CbGpPWpGaD
Acebutolol—SLC22A1—Transmission across Chemical Synapses—CACNA1A—migraine	0.000106	0.00604	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Other—HTR7—migraine	0.000104	0.00591	CbGpPWpGaD
Acebutolol—ADRB1—G alpha (s) signalling events—NPS—migraine	9.65e-05	0.0055	CbGpPWpGaD
Acebutolol—ADRB2—G alpha (s) signalling events—NPS—migraine	9.44e-05	0.00538	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	9.35e-05	0.00532	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	9.14e-05	0.00521	CbGpPWpGaD
Acebutolol—ADRB1—G alpha (s) signalling events—CALCA—migraine	8.86e-05	0.00505	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	8.69e-05	0.00495	CbGpPWpGaD
Acebutolol—ADRB2—G alpha (s) signalling events—CALCA—migraine	8.67e-05	0.00494	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	8.5e-05	0.00484	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—RAMP1—migraine	8.39e-05	0.00478	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—CALCRL—migraine	8.39e-05	0.00478	CbGpPWpGaD
Acebutolol—ADRB1—G alpha (s) signalling events—HTR7—migraine	8.29e-05	0.00472	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—RAMP1—migraine	8.21e-05	0.00468	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—CALCRL—migraine	8.21e-05	0.00468	CbGpPWpGaD
Acebutolol—SLC22A1—Neuronal System—CACNA1A—migraine	8.12e-05	0.00463	CbGpPWpGaD
Acebutolol—ADRB2—G alpha (s) signalling events—HTR7—migraine	8.11e-05	0.00462	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	8.01e-05	0.00456	CbGpPWpGaD
Acebutolol—Body temperature increased—Propranolol—migraine	8e-05	0.0011	CcSEcCtD
Acebutolol—Visual impairment—Timolol—migraine	7.97e-05	0.00109	CcSEcCtD
Acebutolol—Flatulence—Valproic Acid—migraine	7.97e-05	0.00109	CcSEcCtD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—TRPM8—migraine	7.97e-05	0.00454	CbGpPWpGaD
Acebutolol—Pain—Verapamil—migraine	7.96e-05	0.00109	CcSEcCtD
Acebutolol—Constipation—Verapamil—migraine	7.96e-05	0.00109	CcSEcCtD
Acebutolol—Vomiting—Amitriptyline—migraine	7.91e-05	0.00108	CcSEcCtD
Acebutolol—Bradycardia—Gabapentin—migraine	7.84e-05	0.00108	CcSEcCtD
Acebutolol—Rash—Amitriptyline—migraine	7.84e-05	0.00107	CcSEcCtD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	7.83e-05	0.00446	CbGpPWpGaD
Acebutolol—Dermatitis—Amitriptyline—migraine	7.83e-05	0.00107	CcSEcCtD
Acebutolol—Back pain—Valproic Acid—migraine	7.83e-05	0.00107	CcSEcCtD
Acebutolol—Headache—Amitriptyline—migraine	7.79e-05	0.00107	CcSEcCtD
Acebutolol—Rhinitis—Gabapentin—migraine	7.73e-05	0.00106	CcSEcCtD
Acebutolol—Tinnitus—Timolol—migraine	7.72e-05	0.00106	CcSEcCtD
Acebutolol—Feeling abnormal—Verapamil—migraine	7.68e-05	0.00105	CcSEcCtD
Acebutolol—Hallucination—Gabapentin—migraine	7.67e-05	0.00105	CcSEcCtD
Acebutolol—Hypoaesthesia—Gabapentin—migraine	7.67e-05	0.00105	CcSEcCtD
Acebutolol—Pharyngitis—Gabapentin—migraine	7.65e-05	0.00105	CcSEcCtD
Acebutolol—Vision blurred—Valproic Acid—migraine	7.63e-05	0.00105	CcSEcCtD
Acebutolol—Dysuria—Topiramate—migraine	7.57e-05	0.00104	CcSEcCtD
Acebutolol—Connective tissue disorder—Gabapentin—migraine	7.57e-05	0.00104	CcSEcCtD
Acebutolol—Ill-defined disorder—Valproic Acid—migraine	7.51e-05	0.00103	CcSEcCtD
Acebutolol—Angiopathy—Timolol—migraine	7.51e-05	0.00103	CcSEcCtD
Acebutolol—Erectile dysfunction—Topiramate—migraine	7.46e-05	0.00102	CcSEcCtD
Acebutolol—Mediastinal disorder—Timolol—migraine	7.46e-05	0.00102	CcSEcCtD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	7.45e-05	0.00424	CbGpPWpGaD
Acebutolol—Visual impairment—Gabapentin—migraine	7.43e-05	0.00102	CcSEcCtD
Acebutolol—Urticaria—Verapamil—migraine	7.4e-05	0.00101	CcSEcCtD
Acebutolol—Nausea—Amitriptyline—migraine	7.39e-05	0.00101	CcSEcCtD
Acebutolol—Weight increased—Topiramate—migraine	7.37e-05	0.00101	CcSEcCtD
Acebutolol—Alopecia—Timolol—migraine	7.31e-05	0.001	CcSEcCtD
Acebutolol—Malaise—Valproic Acid—migraine	7.3e-05	0.001	CcSEcCtD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	7.28e-05	0.00415	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Other—HTR2A—migraine	7.27e-05	0.00414	CbGpPWpGaD
Acebutolol—Vertigo—Valproic Acid—migraine	7.27e-05	0.000996	CcSEcCtD
Acebutolol—Asthenia—Propranolol—migraine	7.26e-05	0.000996	CcSEcCtD
Acebutolol—Pneumonia—Topiramate—migraine	7.26e-05	0.000996	CcSEcCtD
Acebutolol—Depression—Topiramate—migraine	7.2e-05	0.000987	CcSEcCtD
Acebutolol—Tinnitus—Gabapentin—migraine	7.18e-05	0.000985	CcSEcCtD
Acebutolol—Palpitations—Valproic Acid—migraine	7.15e-05	0.00098	CcSEcCtD
Acebutolol—Cough—Valproic Acid—migraine	7.06e-05	0.000968	CcSEcCtD
Acebutolol—Conjunctivitis—Topiramate—migraine	7.02e-05	0.000962	CcSEcCtD
Acebutolol—Mediastinal disorder—Gabapentin—migraine	6.94e-05	0.000952	CcSEcCtD
Acebutolol—Diarrhoea—Propranolol—migraine	6.93e-05	0.000949	CcSEcCtD
Acebutolol—Chills—Gabapentin—migraine	6.91e-05	0.000948	CcSEcCtD
Acebutolol—Myalgia—Valproic Acid—migraine	6.89e-05	0.000944	CcSEcCtD
Acebutolol—Arthralgia—Valproic Acid—migraine	6.89e-05	0.000944	CcSEcCtD
Acebutolol—Chest pain—Valproic Acid—migraine	6.89e-05	0.000944	CcSEcCtD
Acebutolol—Anxiety—Valproic Acid—migraine	6.86e-05	0.000941	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	6.84e-05	0.000938	CcSEcCtD
Acebutolol—Alopecia—Gabapentin—migraine	6.81e-05	0.000933	CcSEcCtD
Acebutolol—Discomfort—Valproic Acid—migraine	6.81e-05	0.000933	CcSEcCtD
Acebutolol—Vision blurred—Timolol—migraine	6.79e-05	0.00093	CcSEcCtD
Acebutolol—Agranulocytosis—Topiramate—migraine	6.74e-05	0.000924	CcSEcCtD
Acebutolol—Dizziness—Propranolol—migraine	6.7e-05	0.000918	CcSEcCtD
Acebutolol—Asthenia—Verapamil—migraine	6.68e-05	0.000916	CcSEcCtD
Acebutolol—Confusional state—Valproic Acid—migraine	6.66e-05	0.000913	CcSEcCtD
Acebutolol—Flatulence—Gabapentin—migraine	6.61e-05	0.000906	CcSEcCtD
Acebutolol—Oedema—Valproic Acid—migraine	6.6e-05	0.000905	CcSEcCtD
Acebutolol—Bradycardia—Topiramate—migraine	6.6e-05	0.000905	CcSEcCtD
Acebutolol—Pruritus—Verapamil—migraine	6.59e-05	0.000903	CcSEcCtD
Acebutolol—Rhinitis—Topiramate—migraine	6.5e-05	0.000891	CcSEcCtD
Acebutolol—Back pain—Gabapentin—migraine	6.49e-05	0.000889	CcSEcCtD
Acebutolol—Nervous system disorder—Valproic Acid—migraine	6.48e-05	0.000888	CcSEcCtD
Acebutolol—Vertigo—Timolol—migraine	6.47e-05	0.000887	CcSEcCtD
Acebutolol—Syncope—Timolol—migraine	6.46e-05	0.000885	CcSEcCtD
Acebutolol—Hallucination—Topiramate—migraine	6.45e-05	0.000884	CcSEcCtD
Acebutolol—Hypoaesthesia—Topiramate—migraine	6.45e-05	0.000884	CcSEcCtD
Acebutolol—Vomiting—Propranolol—migraine	6.44e-05	0.000882	CcSEcCtD
Acebutolol—Pharyngitis—Topiramate—migraine	6.43e-05	0.000882	CcSEcCtD
Acebutolol—Skin disorder—Valproic Acid—migraine	6.41e-05	0.000879	CcSEcCtD
Acebutolol—Hyperhidrosis—Valproic Acid—migraine	6.38e-05	0.000875	CcSEcCtD
Acebutolol—Rash—Propranolol—migraine	6.38e-05	0.000875	CcSEcCtD
Acebutolol—Dermatitis—Propranolol—migraine	6.38e-05	0.000874	CcSEcCtD
Acebutolol—Diarrhoea—Verapamil—migraine	6.37e-05	0.000873	CcSEcCtD
Acebutolol—Connective tissue disorder—Topiramate—migraine	6.37e-05	0.000873	CcSEcCtD
Acebutolol—Palpitations—Timolol—migraine	6.37e-05	0.000872	CcSEcCtD
Acebutolol—Loss of consciousness—Timolol—migraine	6.33e-05	0.000868	CcSEcCtD
Acebutolol—Vision blurred—Gabapentin—migraine	6.32e-05	0.000866	CcSEcCtD
Acebutolol—Anorexia—Valproic Acid—migraine	6.29e-05	0.000863	CcSEcCtD
Acebutolol—Cough—Timolol—migraine	6.29e-05	0.000862	CcSEcCtD
Acebutolol—Visual impairment—Topiramate—migraine	6.25e-05	0.000856	CcSEcCtD
Acebutolol—Ill-defined disorder—Gabapentin—migraine	6.22e-05	0.000853	CcSEcCtD
Acebutolol—Hypotension—Valproic Acid—migraine	6.17e-05	0.000846	CcSEcCtD
Acebutolol—Dizziness—Verapamil—migraine	6.16e-05	0.000844	CcSEcCtD
Acebutolol—Arthralgia—Timolol—migraine	6.13e-05	0.000841	CcSEcCtD
Acebutolol—Myalgia—Timolol—migraine	6.13e-05	0.000841	CcSEcCtD
Acebutolol—Chest pain—Timolol—migraine	6.13e-05	0.000841	CcSEcCtD
Acebutolol—Anxiety—Timolol—migraine	6.11e-05	0.000838	CcSEcCtD
Acebutolol—ADRB1—GPCR ligand binding—HTR1D—migraine	6.1e-05	0.00347	CbGpPWpGaD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	6.09e-05	0.000835	CcSEcCtD
Acebutolol—Discomfort—Timolol—migraine	6.06e-05	0.00083	CcSEcCtD
Acebutolol—Malaise—Gabapentin—migraine	6.05e-05	0.000829	CcSEcCtD
Acebutolol—Tinnitus—Topiramate—migraine	6.04e-05	0.000828	CcSEcCtD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—ATP1A2—migraine	6.04e-05	0.00344	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—ATP1A3—migraine	6.04e-05	0.00344	CbGpPWpGaD
Acebutolol—Vertigo—Gabapentin—migraine	6.03e-05	0.000826	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Valproic Acid—migraine	6.02e-05	0.000825	CcSEcCtD
Acebutolol—Flushing—Topiramate—migraine	6.02e-05	0.000825	CcSEcCtD
Acebutolol—Syncope—Gabapentin—migraine	6.02e-05	0.000824	CcSEcCtD
Acebutolol—Nausea—Propranolol—migraine	6.01e-05	0.000824	CcSEcCtD
Acebutolol—Insomnia—Valproic Acid—migraine	5.97e-05	0.000819	CcSEcCtD
Acebutolol—ADRB2—GPCR ligand binding—HTR1D—migraine	5.97e-05	0.0034	CbGpPWpGaD
Acebutolol—Paraesthesia—Valproic Acid—migraine	5.93e-05	0.000813	CcSEcCtD
Acebutolol—Palpitations—Gabapentin—migraine	5.93e-05	0.000812	CcSEcCtD
Acebutolol—Confusional state—Timolol—migraine	5.93e-05	0.000812	CcSEcCtD
Acebutolol—Vomiting—Verapamil—migraine	5.92e-05	0.000812	CcSEcCtD
Acebutolol—Loss of consciousness—Gabapentin—migraine	5.9e-05	0.000808	CcSEcCtD
Acebutolol—Dyspnoea—Valproic Acid—migraine	5.89e-05	0.000807	CcSEcCtD
Acebutolol—Angiopathy—Topiramate—migraine	5.88e-05	0.000806	CcSEcCtD
Acebutolol—Oedema—Timolol—migraine	5.88e-05	0.000806	CcSEcCtD
Acebutolol—Rash—Verapamil—migraine	5.87e-05	0.000805	CcSEcCtD
Acebutolol—Somnolence—Valproic Acid—migraine	5.87e-05	0.000805	CcSEcCtD
Acebutolol—Dermatitis—Verapamil—migraine	5.87e-05	0.000804	CcSEcCtD
Acebutolol—Cough—Gabapentin—migraine	5.85e-05	0.000802	CcSEcCtD
Acebutolol—Mediastinal disorder—Topiramate—migraine	5.84e-05	0.000801	CcSEcCtD
Acebutolol—Headache—Verapamil—migraine	5.83e-05	0.0008	CcSEcCtD
Acebutolol—Chills—Topiramate—migraine	5.82e-05	0.000797	CcSEcCtD
Acebutolol—Dyspepsia—Valproic Acid—migraine	5.81e-05	0.000797	CcSEcCtD
Acebutolol—Shock—Timolol—migraine	5.78e-05	0.000793	CcSEcCtD
Acebutolol—Nervous system disorder—Timolol—migraine	5.77e-05	0.00079	CcSEcCtD
Acebutolol—Decreased appetite—Valproic Acid—migraine	5.74e-05	0.000787	CcSEcCtD
Acebutolol—Alopecia—Topiramate—migraine	5.73e-05	0.000785	CcSEcCtD
Acebutolol—Chest pain—Gabapentin—migraine	5.71e-05	0.000783	CcSEcCtD
Acebutolol—Arthralgia—Gabapentin—migraine	5.71e-05	0.000783	CcSEcCtD
Acebutolol—Myalgia—Gabapentin—migraine	5.71e-05	0.000783	CcSEcCtD
Acebutolol—Skin disorder—Timolol—migraine	5.71e-05	0.000783	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Valproic Acid—migraine	5.7e-05	0.000781	CcSEcCtD
Acebutolol—Fatigue—Valproic Acid—migraine	5.69e-05	0.00078	CcSEcCtD
Acebutolol—Anxiety—Gabapentin—migraine	5.69e-05	0.00078	CcSEcCtD
Acebutolol—Hyperhidrosis—Timolol—migraine	5.68e-05	0.000779	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	5.67e-05	0.000777	CcSEcCtD
Acebutolol—ADRB1—GPCR ligand binding—HTR2B—migraine	5.67e-05	0.00323	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	5.66e-05	0.00323	CbGpPWpGaD
Acebutolol—Pain—Valproic Acid—migraine	5.65e-05	0.000774	CcSEcCtD
Acebutolol—Constipation—Valproic Acid—migraine	5.65e-05	0.000774	CcSEcCtD
Acebutolol—Discomfort—Gabapentin—migraine	5.64e-05	0.000773	CcSEcCtD
Acebutolol—Anorexia—Timolol—migraine	5.6e-05	0.000768	CcSEcCtD
Acebutolol—Flatulence—Topiramate—migraine	5.56e-05	0.000762	CcSEcCtD
Acebutolol—ADRB2—GPCR ligand binding—HTR2B—migraine	5.55e-05	0.00316	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	5.54e-05	0.00316	CbGpPWpGaD
Acebutolol—Nausea—Verapamil—migraine	5.53e-05	0.000758	CcSEcCtD
Acebutolol—Confusional state—Gabapentin—migraine	5.52e-05	0.000757	CcSEcCtD
Acebutolol—Hypotension—Timolol—migraine	5.49e-05	0.000753	CcSEcCtD
Acebutolol—Oedema—Gabapentin—migraine	5.47e-05	0.00075	CcSEcCtD
Acebutolol—Back pain—Topiramate—migraine	5.46e-05	0.000748	CcSEcCtD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	5.45e-05	0.00311	CbGpPWpGaD
Acebutolol—Feeling abnormal—Valproic Acid—migraine	5.44e-05	0.000746	CcSEcCtD
Acebutolol—Gastrointestinal pain—Valproic Acid—migraine	5.4e-05	0.00074	CcSEcCtD
Acebutolol—Shock—Gabapentin—migraine	5.39e-05	0.000738	CcSEcCtD
Acebutolol—Nervous system disorder—Gabapentin—migraine	5.37e-05	0.000736	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Timolol—migraine	5.36e-05	0.000734	CcSEcCtD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	5.33e-05	0.00304	CbGpPWpGaD
Acebutolol—Vision blurred—Topiramate—migraine	5.32e-05	0.000729	CcSEcCtD
Acebutolol—Skin disorder—Gabapentin—migraine	5.32e-05	0.000729	CcSEcCtD
Acebutolol—Insomnia—Timolol—migraine	5.32e-05	0.000729	CcSEcCtD
Acebutolol—Hyperhidrosis—Gabapentin—migraine	5.29e-05	0.000725	CcSEcCtD
Acebutolol—Paraesthesia—Timolol—migraine	5.28e-05	0.000724	CcSEcCtD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	5.26e-05	0.003	CbGpPWpGaD
Acebutolol—Urticaria—Valproic Acid—migraine	5.25e-05	0.000719	CcSEcCtD
Acebutolol—Dyspnoea—Timolol—migraine	5.24e-05	0.000718	CcSEcCtD
Acebutolol—Ill-defined disorder—Topiramate—migraine	5.24e-05	0.000718	CcSEcCtD
Acebutolol—Somnolence—Timolol—migraine	5.23e-05	0.000716	CcSEcCtD
Acebutolol—Abdominal pain—Valproic Acid—migraine	5.22e-05	0.000716	CcSEcCtD
Acebutolol—Body temperature increased—Valproic Acid—migraine	5.22e-05	0.000716	CcSEcCtD
Acebutolol—Anorexia—Gabapentin—migraine	5.22e-05	0.000715	CcSEcCtD
Acebutolol—Dyspepsia—Timolol—migraine	5.17e-05	0.000709	CcSEcCtD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	5.15e-05	0.00293	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—HTR3A—migraine	5.14e-05	0.00293	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	5.12e-05	0.00292	CbGpPWpGaD
Acebutolol—Hypotension—Gabapentin—migraine	5.12e-05	0.000701	CcSEcCtD
Acebutolol—Decreased appetite—Timolol—migraine	5.11e-05	0.0007	CcSEcCtD
Acebutolol—Malaise—Topiramate—migraine	5.09e-05	0.000698	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Timolol—migraine	5.08e-05	0.000696	CcSEcCtD
Acebutolol—Vertigo—Topiramate—migraine	5.07e-05	0.000695	CcSEcCtD
Acebutolol—Fatigue—Timolol—migraine	5.07e-05	0.000695	CcSEcCtD
Acebutolol—Syncope—Topiramate—migraine	5.06e-05	0.000694	CcSEcCtD
Acebutolol—Pain—Timolol—migraine	5.03e-05	0.000689	CcSEcCtD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	5.01e-05	0.00285	CbGpPWpGaD
Acebutolol—Musculoskeletal discomfort—Gabapentin—migraine	4.99e-05	0.000684	CcSEcCtD
Acebutolol—Palpitations—Topiramate—migraine	4.99e-05	0.000684	CcSEcCtD
Acebutolol—Loss of consciousness—Topiramate—migraine	4.96e-05	0.00068	CcSEcCtD
Acebutolol—Insomnia—Gabapentin—migraine	4.95e-05	0.000679	CcSEcCtD
Acebutolol—Cough—Topiramate—migraine	4.92e-05	0.000675	CcSEcCtD
Acebutolol—Paraesthesia—Gabapentin—migraine	4.92e-05	0.000674	CcSEcCtD
Acebutolol—Dyspnoea—Gabapentin—migraine	4.88e-05	0.000669	CcSEcCtD
Acebutolol—Somnolence—Gabapentin—migraine	4.87e-05	0.000667	CcSEcCtD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	4.85e-05	0.00276	CbGpPWpGaD
Acebutolol—Feeling abnormal—Timolol—migraine	4.84e-05	0.000664	CcSEcCtD
Acebutolol—Dyspepsia—Gabapentin—migraine	4.82e-05	0.00066	CcSEcCtD
Acebutolol—Gastrointestinal pain—Timolol—migraine	4.81e-05	0.000659	CcSEcCtD
Acebutolol—Arthralgia—Topiramate—migraine	4.8e-05	0.000659	CcSEcCtD
Acebutolol—Chest pain—Topiramate—migraine	4.8e-05	0.000659	CcSEcCtD
Acebutolol—Myalgia—Topiramate—migraine	4.8e-05	0.000659	CcSEcCtD
Acebutolol—Anxiety—Topiramate—migraine	4.79e-05	0.000656	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	4.77e-05	0.000654	CcSEcCtD
Acebutolol—Decreased appetite—Gabapentin—migraine	4.76e-05	0.000652	CcSEcCtD
Acebutolol—Discomfort—Topiramate—migraine	4.75e-05	0.000651	CcSEcCtD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	4.75e-05	0.0027	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—CALCRL—migraine	4.74e-05	0.0027	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—RAMP1—migraine	4.74e-05	0.0027	CbGpPWpGaD
Acebutolol—Asthenia—Valproic Acid—migraine	4.74e-05	0.000649	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Gabapentin—migraine	4.73e-05	0.000648	CcSEcCtD
Acebutolol—Fatigue—Gabapentin—migraine	4.72e-05	0.000647	CcSEcCtD
Acebutolol—Pain—Gabapentin—migraine	4.68e-05	0.000642	CcSEcCtD
Acebutolol—Constipation—Gabapentin—migraine	4.68e-05	0.000642	CcSEcCtD
Acebutolol—Pruritus—Valproic Acid—migraine	4.67e-05	0.00064	CcSEcCtD
Acebutolol—ABCB1—Transmembrane transport of small molecules—TRPM8—migraine	4.67e-05	0.00266	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	4.67e-05	0.00266	CbGpPWpGaD
Acebutolol—Urticaria—Timolol—migraine	4.67e-05	0.00064	CcSEcCtD
Acebutolol—Abdominal pain—Timolol—migraine	4.65e-05	0.000637	CcSEcCtD
Acebutolol—Body temperature increased—Timolol—migraine	4.65e-05	0.000637	CcSEcCtD
Acebutolol—Confusional state—Topiramate—migraine	4.64e-05	0.000637	CcSEcCtD
Acebutolol—ADRB2—GPCR downstream signaling—CALCRL—migraine	4.64e-05	0.00264	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—RAMP1—migraine	4.64e-05	0.00264	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	4.61e-05	0.00263	CbGpPWpGaD
Acebutolol—Oedema—Topiramate—migraine	4.61e-05	0.000631	CcSEcCtD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	4.6e-05	0.00262	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	4.6e-05	0.00262	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	4.57e-05	0.0026	CbGpPWpGaD
Acebutolol—Shock—Topiramate—migraine	4.53e-05	0.000621	CcSEcCtD
Acebutolol—Diarrhoea—Valproic Acid—migraine	4.52e-05	0.000619	CcSEcCtD
Acebutolol—Nervous system disorder—Topiramate—migraine	4.52e-05	0.000619	CcSEcCtD
Acebutolol—Feeling abnormal—Gabapentin—migraine	4.51e-05	0.000618	CcSEcCtD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR7—migraine	4.51e-05	0.00257	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	4.51e-05	0.00257	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	4.5e-05	0.00256	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	4.5e-05	0.00256	CbGpPWpGaD
Acebutolol—Gastrointestinal pain—Gabapentin—migraine	4.48e-05	0.000614	CcSEcCtD
Acebutolol—Skin disorder—Topiramate—migraine	4.47e-05	0.000613	CcSEcCtD
Acebutolol—Hyperhidrosis—Topiramate—migraine	4.45e-05	0.00061	CcSEcCtD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	4.41e-05	0.00251	CbGpPWpGaD
Acebutolol—Anorexia—Topiramate—migraine	4.39e-05	0.000602	CcSEcCtD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	4.39e-05	0.0025	CbGpPWpGaD
Acebutolol—Dizziness—Valproic Acid—migraine	4.37e-05	0.000599	CcSEcCtD
Acebutolol—Urticaria—Gabapentin—migraine	4.35e-05	0.000596	CcSEcCtD
Acebutolol—Body temperature increased—Gabapentin—migraine	4.33e-05	0.000593	CcSEcCtD
Acebutolol—Abdominal pain—Gabapentin—migraine	4.33e-05	0.000593	CcSEcCtD
Acebutolol—ADRB1—Signaling by GPCR—CALCRL—migraine	4.31e-05	0.00245	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—RAMP1—migraine	4.31e-05	0.00245	CbGpPWpGaD
Acebutolol—Hypotension—Topiramate—migraine	4.3e-05	0.00059	CcSEcCtD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	4.29e-05	0.00244	CbGpPWpGaD
Acebutolol—Asthenia—Timolol—migraine	4.22e-05	0.000578	CcSEcCtD
Acebutolol—ADRB2—Signaling by GPCR—RAMP1—migraine	4.21e-05	0.0024	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CALCRL—migraine	4.21e-05	0.0024	CbGpPWpGaD
Acebutolol—Vomiting—Valproic Acid—migraine	4.2e-05	0.000575	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Topiramate—migraine	4.2e-05	0.000575	CcSEcCtD
Acebutolol—Insomnia—Topiramate—migraine	4.17e-05	0.000571	CcSEcCtD
Acebutolol—Rash—Valproic Acid—migraine	4.16e-05	0.000571	CcSEcCtD
Acebutolol—Dermatitis—Valproic Acid—migraine	4.16e-05	0.00057	CcSEcCtD
Acebutolol—Pruritus—Timolol—migraine	4.16e-05	0.00057	CcSEcCtD
Acebutolol—Headache—Valproic Acid—migraine	4.14e-05	0.000567	CcSEcCtD
Acebutolol—Paraesthesia—Topiramate—migraine	4.14e-05	0.000567	CcSEcCtD
Acebutolol—Dyspnoea—Topiramate—migraine	4.11e-05	0.000563	CcSEcCtD
Acebutolol—Somnolence—Topiramate—migraine	4.09e-05	0.000561	CcSEcCtD
Acebutolol—Dyspepsia—Topiramate—migraine	4.05e-05	0.000556	CcSEcCtD
Acebutolol—Diarrhoea—Timolol—migraine	4.02e-05	0.000551	CcSEcCtD
Acebutolol—Decreased appetite—Topiramate—migraine	4e-05	0.000549	CcSEcCtD
Acebutolol—ABCB1—HIF-1-alpha transcription factor network—FOS—migraine	4e-05	0.00228	CbGpPWpGaD
Acebutolol—Gastrointestinal disorder—Topiramate—migraine	3.98e-05	0.000545	CcSEcCtD
Acebutolol—Fatigue—Topiramate—migraine	3.97e-05	0.000544	CcSEcCtD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	3.95e-05	0.00225	CbGpPWpGaD
Acebutolol—Constipation—Topiramate—migraine	3.94e-05	0.00054	CcSEcCtD
Acebutolol—Pain—Topiramate—migraine	3.94e-05	0.00054	CcSEcCtD
Acebutolol—Asthenia—Gabapentin—migraine	3.93e-05	0.000538	CcSEcCtD
Acebutolol—Nausea—Valproic Acid—migraine	3.92e-05	0.000538	CcSEcCtD
Acebutolol—Dizziness—Timolol—migraine	3.89e-05	0.000533	CcSEcCtD
Acebutolol—Pruritus—Gabapentin—migraine	3.87e-05	0.000531	CcSEcCtD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	3.86e-05	0.0022	CbGpPWpGaD
Acebutolol—Feeling abnormal—Topiramate—migraine	3.8e-05	0.00052	CcSEcCtD
Acebutolol—Gastrointestinal pain—Topiramate—migraine	3.77e-05	0.000516	CcSEcCtD
Acebutolol—Diarrhoea—Gabapentin—migraine	3.75e-05	0.000513	CcSEcCtD
Acebutolol—Vomiting—Timolol—migraine	3.74e-05	0.000512	CcSEcCtD
Acebutolol—Rash—Timolol—migraine	3.71e-05	0.000508	CcSEcCtD
Acebutolol—Dermatitis—Timolol—migraine	3.7e-05	0.000508	CcSEcCtD
Acebutolol—ADRB1—GPCR ligand binding—HTR1B—migraine	3.69e-05	0.0021	CbGpPWpGaD
Acebutolol—Headache—Timolol—migraine	3.68e-05	0.000505	CcSEcCtD
Acebutolol—Urticaria—Topiramate—migraine	3.66e-05	0.000501	CcSEcCtD
Acebutolol—Body temperature increased—Topiramate—migraine	3.64e-05	0.000499	CcSEcCtD
Acebutolol—Abdominal pain—Topiramate—migraine	3.64e-05	0.000499	CcSEcCtD
Acebutolol—Dizziness—Gabapentin—migraine	3.62e-05	0.000496	CcSEcCtD
Acebutolol—ADRB2—GPCR ligand binding—HTR1B—migraine	3.61e-05	0.00206	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—HTR1A—migraine	3.56e-05	0.00203	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—ATP1A2—migraine	3.54e-05	0.00202	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—ATP1A3—migraine	3.54e-05	0.00202	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—NPS—migraine	3.5e-05	0.002	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—TAC1—migraine	3.5e-05	0.002	CbGpPWpGaD
Acebutolol—Nausea—Timolol—migraine	3.49e-05	0.000479	CcSEcCtD
Acebutolol—Vomiting—Gabapentin—migraine	3.48e-05	0.000477	CcSEcCtD
Acebutolol—ADRB2—GPCR ligand binding—HTR1A—migraine	3.48e-05	0.00198	CbGpPWpGaD
Acebutolol—Rash—Gabapentin—migraine	3.45e-05	0.000473	CcSEcCtD
Acebutolol—Dermatitis—Gabapentin—migraine	3.45e-05	0.000473	CcSEcCtD
Acebutolol—ADRB1—GPCR downstream signaling—HTR1D—migraine	3.45e-05	0.00196	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—HTR2C—migraine	3.43e-05	0.00196	CbGpPWpGaD
Acebutolol—Headache—Gabapentin—migraine	3.43e-05	0.00047	CcSEcCtD
Acebutolol—ADRB2—GPCR ligand binding—NPS—migraine	3.43e-05	0.00195	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—TAC1—migraine	3.43e-05	0.00195	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—HTR1D—migraine	3.37e-05	0.00192	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—HTR2C—migraine	3.36e-05	0.00191	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—EDNRA—migraine	3.34e-05	0.0019	CbGpPWpGaD
Acebutolol—Asthenia—Topiramate—migraine	3.3e-05	0.000453	CcSEcCtD
Acebutolol—ADRB2—GPCR ligand binding—EDNRA—migraine	3.27e-05	0.00186	CbGpPWpGaD
Acebutolol—Pruritus—Topiramate—migraine	3.26e-05	0.000447	CcSEcCtD
Acebutolol—Nausea—Gabapentin—migraine	3.25e-05	0.000446	CcSEcCtD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	3.23e-05	0.00184	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—CALCA—migraine	3.22e-05	0.00183	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—HTR2B—migraine	3.2e-05	0.00182	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	3.16e-05	0.0018	CbGpPWpGaD
Acebutolol—Diarrhoea—Topiramate—migraine	3.15e-05	0.000432	CcSEcCtD
Acebutolol—ADRB2—GPCR ligand binding—CALCA—migraine	3.15e-05	0.00179	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—HTR2B—migraine	3.13e-05	0.00179	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—HTR1D—migraine	3.13e-05	0.00178	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—HTR1D—migraine	3.06e-05	0.00174	CbGpPWpGaD
Acebutolol—Dizziness—Topiramate—migraine	3.05e-05	0.000417	CcSEcCtD
Acebutolol—ABCB1—Transmembrane transport of small molecules—HTR3A—migraine	3.01e-05	0.00171	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—HTR7—migraine	3.01e-05	0.00171	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—HTR7—migraine	2.94e-05	0.00168	CbGpPWpGaD
Acebutolol—Vomiting—Topiramate—migraine	2.93e-05	0.000401	CcSEcCtD
Acebutolol—ADRB1—Signaling by GPCR—HTR2B—migraine	2.91e-05	0.00166	CbGpPWpGaD
Acebutolol—Rash—Topiramate—migraine	2.9e-05	0.000398	CcSEcCtD
Acebutolol—Dermatitis—Topiramate—migraine	2.9e-05	0.000398	CcSEcCtD
Acebutolol—Headache—Topiramate—migraine	2.89e-05	0.000395	CcSEcCtD
Acebutolol—ADRB2—Signaling by GPCR—HTR2B—migraine	2.85e-05	0.00162	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	2.77e-05	0.00158	CbGpPWpGaD
Acebutolol—Nausea—Topiramate—migraine	2.74e-05	0.000375	CcSEcCtD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	2.71e-05	0.00154	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—RAMP1—migraine	2.54e-05	0.00145	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CALCRL—migraine	2.54e-05	0.00145	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	2.53e-05	0.00144	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—RAMP1—migraine	2.49e-05	0.00142	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CALCRL—migraine	2.49e-05	0.00142	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—HTR2A—migraine	2.11e-05	0.0012	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—HTR1B—migraine	2.09e-05	0.00119	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—HTR2A—migraine	2.06e-05	0.00117	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CACNA1A—migraine	2.05e-05	0.00117	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—HTR1B—migraine	2.04e-05	0.00116	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—HTR1A—migraine	2.01e-05	0.00114	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—NPS—migraine	1.98e-05	0.00113	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—TAC1—migraine	1.98e-05	0.00113	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—HTR1A—migraine	1.97e-05	0.00112	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—HTR2C—migraine	1.94e-05	0.00111	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—TAC1—migraine	1.94e-05	0.0011	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—NPS—migraine	1.94e-05	0.0011	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—HTR2C—migraine	1.9e-05	0.00108	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—HTR1B—migraine	1.9e-05	0.00108	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	1.9e-05	0.00108	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—EDNRA—migraine	1.89e-05	0.00108	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—TNF—migraine	1.86e-05	0.00106	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—HTR1B—migraine	1.85e-05	0.00106	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HTR1D—migraine	1.85e-05	0.00105	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—EDNRA—migraine	1.85e-05	0.00105	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—HTR1A—migraine	1.83e-05	0.00104	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—CALCA—migraine	1.82e-05	0.00104	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HTR1D—migraine	1.81e-05	0.00103	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—NPS—migraine	1.8e-05	0.00102	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—TAC1—migraine	1.8e-05	0.00102	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—HTR1A—migraine	1.79e-05	0.00102	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—CALCA—migraine	1.78e-05	0.00101	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—HTR2C—migraine	1.76e-05	0.001	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—TAC1—migraine	1.76e-05	0.001	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—NPS—migraine	1.76e-05	0.001	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—HTR2C—migraine	1.72e-05	0.000982	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HTR2B—migraine	1.72e-05	0.000979	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—EDNRA—migraine	1.71e-05	0.000977	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—HTR7—migraine	1.7e-05	0.000968	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HTR2B—migraine	1.68e-05	0.000958	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—EDNRA—migraine	1.68e-05	0.000955	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—HTR7—migraine	1.66e-05	0.000947	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—CALCA—migraine	1.65e-05	0.00094	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CALCA—migraine	1.61e-05	0.00092	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—HTR7—migraine	1.54e-05	0.000879	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—LRP1—migraine	1.51e-05	0.000862	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—HTR7—migraine	1.51e-05	0.00086	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—LRP1—migraine	1.48e-05	0.000843	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CACNA1A—migraine	1.2e-05	0.000683	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—HTR2A—migraine	1.19e-05	0.000678	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—HTR2A—migraine	1.16e-05	0.000663	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NOTCH4—migraine	1.16e-05	0.000661	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NOTCH4—migraine	1.14e-05	0.000647	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CACNA1A—migraine	1.13e-05	0.000644	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HTR1B—migraine	1.12e-05	0.000638	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HTR1B—migraine	1.1e-05	0.000624	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—HTR2A—migraine	1.08e-05	0.000616	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HTR1A—migraine	1.08e-05	0.000614	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TAC1—migraine	1.06e-05	0.000605	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NPS—migraine	1.06e-05	0.000605	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PGR—migraine	1.06e-05	0.000605	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—HTR2A—migraine	1.06e-05	0.000603	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HTR1A—migraine	1.05e-05	0.000601	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HTR2C—migraine	1.04e-05	0.000593	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TAC1—migraine	1.04e-05	0.000592	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NPS—migraine	1.04e-05	0.000592	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PGR—migraine	1.04e-05	0.000592	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HTR2C—migraine	1.02e-05	0.00058	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—EDNRA—migraine	1.01e-05	0.000577	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—EDNRA—migraine	9.91e-06	0.000564	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NOTCH3—migraine	9.87e-06	0.000562	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CALCA—migraine	9.75e-06	0.000555	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NOTCH3—migraine	9.66e-06	0.00055	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CALCA—migraine	9.54e-06	0.000543	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—migraine	9.18e-06	0.000523	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HTR7—migraine	9.12e-06	0.00052	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HTR7—migraine	8.92e-06	0.000508	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TGFBR2—migraine	7.85e-06	0.000447	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TGFBR2—migraine	7.68e-06	0.000438	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—MTHFR—migraine	6.77e-06	0.000385	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HTR2A—migraine	6.39e-06	0.000364	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HTR2A—migraine	6.25e-06	0.000356	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—ESR1—migraine	5.67e-06	0.000323	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—ESR1—migraine	5.55e-06	0.000316	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—MTHFR—migraine	3.97e-06	0.000226	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—MTHFR—migraine	3.74e-06	0.000213	CbGpPWpGaD
